Sepsis Diagnostics Market Size, Share, Analysis, Trends, Growth, 2032

Sepsis Diagnostics Industry Prospective:

The global sepsis diagnostics market size was worth around USD 643.29 Million in 2023 and is predicted to grow to around USD 1,182.66 Million by 2032 with a compound annual growth rate (CAGR) of roughly 7.00% between 2024 and 2032.

Request Free Sample

The report analyzes the global sepsis diagnostics market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the sepsis diagnostics industry. 

The report covers a forecast and an analysis of the sepsis diagnostics market on a global and regional level. The study provides historic data for 2018 and 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million). The study includes drivers and restraints of the sepsis diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the sepsis diagnostics market on a global level.

In order to give the users of this report a comprehensive view of the sepsis diagnostics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

Sepsis Diagnostics Market: Growth Drivers

In the future, the global market for sepsis diagnostics is projected to see growth as a result of the growing need for antibiotic-resistant bacterial strains and the rising number of cases of hospital-acquired illnesses. In the years to come, it is projected that the most significant growth driver of the worldwide sepsis diagnostics market will be the continuing increase in the number of HAIs, which stands for hospital-acquired infections. Those individuals who have a compromised immune system or who are at a higher risk of being diagnosed with chronic diseases are the most likely to develop sepsis as a result of HAIs.

Sepsis Diagnostics Market: Report Scope

Sepsis Diagnostics Market: Segmentation

The study provides a decisive view of the sepsis diagnostics market by segmenting the market based on product, technology, pathogen type, method, test type, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries.

On the basis of product, technology, pathogen type, method, and test type, the global market for sepsis diagnostics is divided into different segments. Blood culture media, test kits and reagents, and instruments are the three categories that are used to categorize the market according to product type. Blood culture media is projected to hold the greatest share of the sepsis diagnostics market throughout the projection timeline.

This is due to the enormous need that physicians have for testing procedures that are both cost-effective and conventional. Immunoassays, microbiology, microfluidics, molecular diagnostics, biomarkers, and flow cytometry are all included in the technology section of the market. Due to the fact that it is able to quantitatively detect microorganisms for sepsis diagnosis through culture media test applications, the microbiology segment is projected to become the dominant player in the worldwide market for sepsis diagnostics in the future. The market for sepsis diagnostics covers fungal sepsis, bacterial sepsis, and other types of sepsis, according to the kind of pathogen.

There are two types of bacteria that are classified as gram-negative bacteria and gram-positive bacteria inside the bacterial sepsis segment. Due to the fact that the majority of patients are affected by gram-negative bacterial sepsis, the segment of the market that deals with bacterial sepsis held the greatest market share in 2017. Furthermore, due to the high frequency of Candida infection that results in septic poisoning among patients, the fungal sepsis segment is predicted to register the highest CAGR in the future.

This is because of the fact that the segment is expected to be the most lucrative. The market for sepsis diagnostics is comprised of both automated diagnostics and conventional diagnostics, according to the treatment technique. In 2017, the traditional diagnostics sector retained the biggest market share. This was due to the fact that it was both cost-effective and able to make quick adjustments for optimal therapy. Depending on the type of test, the market can be divided into two categories: laboratory tests and point-of-care tests. Due to the fact that a significant percentage of blood culture tests are carried out in laboratories, laboratory tests held the highest market share in 2017.

Sepsis Diagnostics Market: Competitive Analysis

Some leading players of the global sepsis diagnostics market are

• Danaher
• Immunexpress
• Biomerieux
• Thermo Fisher Scientific
• Becton
• Dickinson
• and Company
• Response Biomedical
• Bruker
• Luminex
• Roche Diagnostics
• T2 Biosystems
• Among Others

This report segments the global sepsis diagnostics market into:

Global Sepsis Diagnostics Market: Product Analysis

• Instruments
• Blood Culture Media
• Assay Kits and Reagents

Global Sepsis Diagnostics Market: Technology Analysis

• Microbiology
• Molecular Diagnostics 
• Immunoassays
• Flow Cytometry
• Microfluidics
• Biomarkers

Global Sepsis Diagnostics Market: Pathogen Type Analysis

• Bacterial Sepsis 
  • Gram-Positive Bacteria
  • Gram-Negative Bacteria
• Fungal Sepsis
• Others

Global Sepsis Diagnostics Market: Method Analysis

• Conventional Diagnostics
• Automated Diagnostics

Global Sepsis Diagnostics Market: Test Type Analysis

• Laboratory Tests 
• Point-Of-Care Tests

Global Sepsis Diagnostics Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa